|
Mr. Morhet's experience in the pharmaceutical industry includes positions at Baxter Healthcare, Merck and AstraZeneca. He has experience with pharmaceutical product development, manufacturing, regulatory affairs, product commercialization and working with the FDA for both drug and device applications. Most recently, Mr. Morhet's focus has been on cellular and intra-cellular anti-cancer drug development as Vice President and General Manager of Zila Inc., where he refocused Zila's long running cancer research, clinical development and manufacturing programs. Morhet also founded and directed Zila Biotechnology, Inc., a comprehensive research, development and licensing business. He also has experience in the areas of investor relations and corporate finance. He graduated from Stephen F. Austin State University and attended the Executive MBA program at Arizona State University. | 